This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AMGN, DOW, GDOT, S, XOM

Sprint Nextel (S) upgraded at UBS to Buy from Neutral, UBS said. $6 price target. Better than expected NV, wireless environment.

Starbucks (SBUX) downgraded at Baird from Outperform to Neutral, Robert Baird said. $50 price target. Sales have suddenly slowed down in recent months.

Valley National (VLY) downgraded at JP Morgan to Underweight, JP Morgan said. Company is seeing a lower net interest margin and the dividend may be at risk.

Vistaprint (VPRT) downgraded at Craig-Hallum from Buy to Hold, Craig-Hallum said. $35 price target. European business continues to slide.

ExxonMobil (XOM - Get Report) downgraded at UBS to Neutral from Buy, UBS said. $90 price target. Low quality 2Q EPS and premium multiple.

STOCK COMMENTS / EPS CHANGES

Amgen (AMGN - Get Report) estimates, target raised at Credit Suisse. Shares of AMGN now seen reaching $90, according to Credit Suisse. Estimates also increased, as the company should generate higher sales growth. Outperform rating.

Boston Scientific (BSX) numbers reduced at Credit Suisse. Shares of BSX now seen reaching $6.50, according to Credit Suisse. Estimates also cut, as the company is realizing higher operating costs. Outperform rating.

BorgWarner (BWA) added to Priority Stock List at Wells. BWA was placed on the Priority Stock list, according to Wells Fargo. Stock has lagged, though the company should be able to meet guidance in the coming quarters.

Borg Warner numbers cut at Citigroup. Shares of BWA now seen reaching $73, Citigroup said. Estimates also lowered as macro overshadows margin/booking positives. Neutral rating.

CA (CA) numbers lowered at Oppenheimer. Shares of CA now seen reaching $28, Oppenheimer said. Estimates also lowered on cautious stance. Outperform rating.

Cameron (CAM) estimates, target increased at Morgan Stanley. CAM estimates were raised through 2014, Morgan Stanley said. Company appears to be gaining market share. Overweight rating and nwe $72 price target.

Celgene (CELG) numbers raised at Jefferies. Shares of CELG now seen reaching $80, Jefferies said. Estimates also raised on strong earnings. Buy rating.

Colgate-Palmolive (CL) numbers raised at UBS. Shares of CL now seen reaching $104, UBS said. Estimates also increased as underlying fundamentals improve despite FX impact. Neutral rating.

Dow Chemical (DOW - Get Report) numbers lowered at UBS. Shares of DOW now seen reaching $36, UBS said. Estimates also lowered as back half of 2012 will be challenging.

Dow Chemical numbers lowered at Jefferies. Shares of DOW now seen reaching $29, Jefferies said. Estimates also lowered on extended soft patch. Hold rating.

Equinix (EQIX) estimates, target increased at Deutsche. EQIX estimates were raised through 2013, Deutsche Bank said. Company is seeing strong core demand. Buy rating and new $230 price target.

Expedia (EXPE) estimates, target boosted at Credit Suisse. Shares of EXPE now seen reaching $51, according to Credit Suisse. Estimates also upped, given higher realized conversion rates. Neutral rating.

Facebook (FB) estimates, target cut at Wedbush. Shares of FB now seen reaching $35, according to Wedbush. Estimates also reduced, given higher spending on future business growth. Outperform rating.

Hill-Rom (HRC) numbers reduced at Morgan Stanley. HRC estimates were cut through 2013, Morgan Stanley said. Company posted a disappointing outlook. Overweight rating and new $31 price target.

Hershey (HSY) estimates, target increased at Morgan Stanley. HSY estimates were raised through 2014, Morgan Stanley said. Company is carrying a lot of business momentum into the second half of the year. Equal-weight rating and new $68 price target.

KBR (KBR) estimates, target raised at Credit Suisse. Shares of KBR now seen reaching $48, according to Credit Suisse. Estimates also increased, given the company's new guidance. Outperform rating.

McKesson (MCK) estimates, target raised at Credit Suisse. Shares of MCK now seen reaching $107, according to Credit Suisse. Estimates also increased, as the company should continue to exceed guidance. Outperform rating.

Mead Johnson (MJN) numbers reduced at Credit Suisse. Shares of MJN now seen reaching $84, according to Credit Suisse. Estimates also cut, as trends remain soft in China. Outperform rating.

National Oilwell Varco (NOV) numbers raised at Citigroup. Shares of NOV now seen reaching $96, Citigroup said. Estimates also increased on strong orders and guidance on rig tech market. Buy rating.

Occidental Petroleum (OXY) numbers lowered at Credit Suisse. Shares of OXY now seen reaching $114, according to Credit Suisse. Estimates also cut, given reduced production growth expectations. Outperform rating.

Precision Castparts (PCP) numbers boosted at Credit Suisse. Shares of PCP now seen reaching $191, according to Credit Suisse. Estimates also upped, as the company is realizing higher margins. Outperform rating.

MetroPCS (PCS) numbers raised at UBS. Shares of PCS now seen reaching $9, UBS said. Estimates also increased on increasing margin outlook. Neutral rating.

Starbucks (SBUX) estimates, target cut at Credit Suisse. Shares of SBUX now seen reaching $64, according to Credit Suisse. Estimates also reduced, as the company is seeing lower near-term sales and investing in new growth vehicles. Outperform rating.

Universal Health (UHS) numbers reduced at Credit Suisse. Shares of UHS now seen reaching $51, according to Credit Suisse. Estimates also cut, as the company is cutting costs and the acute care business appears to be stabilizing. Outperform rating.

United Technologies (UTX) numbers lowered at Jefferies. Shares of UTX now seen reaching $88, Jefferies said. Estimates also lowered on operational grind. Buy rating.

United Technologies numbers lowered at Oppenheimer. Shares of UTX now seen reaching $87, Oppenheimer said. Estimates also lowered on transitional year. Outperform rating.

Verisign (VRSN) estimates, target raised at Credit Suisse. Shares of VRSN now seen reaching $50, according to Credit Suisse. Estimates also increased, as the company is realizing higher margins. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AMGN $164.82 1.50%
DOW $51.28 -0.37%
GDOT $16.64 -0.18%
S $5.32 1.20%
XOM $87.70 0.79%

Markets

DOW 18,100.43 +62.46 0.35%
S&P 500 2,112.82 +3.90 0.18%
NASDAQ 5,069.6710 +9.4250 0.19%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs